Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP834816.RA8pR9nCDwXKJplWd9fQhNtKeQqqm096gV-1hnsS-nzwo130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP834816.RA8pR9nCDwXKJplWd9fQhNtKeQqqm096gV-1hnsS-nzwo130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP834816.RA8pR9nCDwXKJplWd9fQhNtKeQqqm096gV-1hnsS-nzwo130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP834816.RA8pR9nCDwXKJplWd9fQhNtKeQqqm096gV-1hnsS-nzwo130_provenance.
- NP834816.RA8pR9nCDwXKJplWd9fQhNtKeQqqm096gV-1hnsS-nzwo130_assertion description "[Targeted stimulation of the caspase-8 promoter by interferons alpha and gamma, cytotoxic drugs or p53 can substantially sensitize hepatoma cells for apoptosis, whereas hepatocellular carcinoma frequently present an inactive caspase-8 gene promoter.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP834816.RA8pR9nCDwXKJplWd9fQhNtKeQqqm096gV-1hnsS-nzwo130_provenance.
- NP834816.RA8pR9nCDwXKJplWd9fQhNtKeQqqm096gV-1hnsS-nzwo130_assertion evidence source_evidence_literature NP834816.RA8pR9nCDwXKJplWd9fQhNtKeQqqm096gV-1hnsS-nzwo130_provenance.
- NP834816.RA8pR9nCDwXKJplWd9fQhNtKeQqqm096gV-1hnsS-nzwo130_assertion SIO_000772 22153863 NP834816.RA8pR9nCDwXKJplWd9fQhNtKeQqqm096gV-1hnsS-nzwo130_provenance.
- NP834816.RA8pR9nCDwXKJplWd9fQhNtKeQqqm096gV-1hnsS-nzwo130_assertion wasDerivedFrom befree-20140225 NP834816.RA8pR9nCDwXKJplWd9fQhNtKeQqqm096gV-1hnsS-nzwo130_provenance.
- NP834816.RA8pR9nCDwXKJplWd9fQhNtKeQqqm096gV-1hnsS-nzwo130_assertion wasGeneratedBy ECO_0000203 NP834816.RA8pR9nCDwXKJplWd9fQhNtKeQqqm096gV-1hnsS-nzwo130_provenance.
- befree-20140225 importedOn "2014-02-25" NP834816.RA8pR9nCDwXKJplWd9fQhNtKeQqqm096gV-1hnsS-nzwo130_provenance.